NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 87 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $78,000 | -63.9% | 41,467 | -7.3% | 0.00% | – |
| Q4 2021 | $216,000 | -34.1% | 44,743 | -1.3% | 0.00% | – |
| Q3 2021 | $328,000 | -29.6% | 45,334 | -10.2% | 0.00% | -100.0% |
| Q2 2021 | $466,000 | +7.6% | 50,457 | +43.3% | 0.00% | 0.0% |
| Q1 2021 | $433,000 | -18.1% | 35,203 | -6.1% | 0.00% | 0.0% |
| Q4 2020 | $529,000 | +29.3% | 37,483 | +10.1% | 0.00% | 0.0% |
| Q3 2020 | $409,000 | -31.3% | 34,043 | -5.0% | 0.00% | 0.0% |
| Q2 2020 | $595,000 | – | 35,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,047,300 | $5,048,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 212,500 | $1,024,000 | 0.74% |
| Redmile Group, LLC | 3,490,835 | $16,826,000 | 0.38% |
| Kynam Capital Management, LP | 147,000 | $709,000 | 0.38% |
| EcoR1 Capital, LLC | 860,619 | $4,148,000 | 0.13% |
| Baker Brothers Advisors | 3,821,740 | $18,421,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,899 | $631,000 | 0.08% |
| Sio Capital Management, LLC | 38,312 | $185,000 | 0.06% |
| Highland Private Wealth Management | 46,999 | $227,000 | 0.03% |
| XTX Topco Ltd | 10,018 | $48,000 | 0.03% |